Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gentile

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Current Medicinal Chemistry|November 1, 2006
Treating chronic hepatitis B: today and tomorrowG Borgia, I Gentile
The Journal of Invasive Cardiology|December 25, 2010
Patent ductus arteriosus associated with aberrant right subclavian artery: two cases, one successful interventional closure of PDAJorge E Gomez, Jorge I Gentile
Infection|October 18, 2003
HIV and hepatitis C virus: facts and controversiesG Borgia, L Reynaud, I Gentile, et al.
Current Medicinal Chemistry|March 12, 2009
Telaprevir: a promising protease inhibitor for the treatment of hepatitis C virus infectionI Gentile, C Viola, F Borgia, et al.
Current Medicinal Chemistry|July 16, 2013
A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvirI Gentile, F Borgia, A R Buonomo, et al.
Parassitologia|August 13, 2004
[Cystic echinococcosis in humans: our clinic experience]D Tiseo, F Borrelli, I Gentile, et al.
Current Medicinal Chemistry|December 31, 2013
Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5AI Gentile, F Borgia, N Coppola, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 17, 2001
Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis CG Borgia, L Reynaud, I Gentile, et al.
Acta Diabetologica|August 28, 2007
A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?G Tosone, G Borgia, I Gentile, et al.
Infection|April 27, 2000
A case of paracoccidioidomycosis: experience with long-term therapyG Borgia, L Reynaud, R Cerini, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Medicinal Chemistry|November 1, 2006
Treating chronic hepatitis B: today and tomorrowG Borgia, I Gentile
The Journal of Invasive Cardiology|December 25, 2010
Patent ductus arteriosus associated with aberrant right subclavian artery: two cases, one successful interventional closure of PDAJorge E Gomez, Jorge I Gentile
Infection|October 18, 2003
HIV and hepatitis C virus: facts and controversiesG Borgia, L Reynaud, I Gentile, et al.
Current Medicinal Chemistry|March 12, 2009
Telaprevir: a promising protease inhibitor for the treatment of hepatitis C virus infectionI Gentile, C Viola, F Borgia, et al.
Current Medicinal Chemistry|July 16, 2013
A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvirI Gentile, F Borgia, A R Buonomo, et al.
Parassitologia|August 13, 2004
[Cystic echinococcosis in humans: our clinic experience]D Tiseo, F Borrelli, I Gentile, et al.
Current Medicinal Chemistry|December 31, 2013
Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5AI Gentile, F Borgia, N Coppola, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 17, 2001
Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis CG Borgia, L Reynaud, I Gentile, et al.
Acta Diabetologica|August 28, 2007
A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?G Tosone, G Borgia, I Gentile, et al.
Infection|April 27, 2000
A case of paracoccidioidomycosis: experience with long-term therapyG Borgia, L Reynaud, R Cerini, et al.
Pageof 3